Stockscreener 앱 받기
3.54
4.58%
-0.17
전일 마감가:
$3.71
열려 있는:
$3.67
하루 거래량:
85,088
Relative Volume:
0.11
시가총액:
$8.02M
수익:
-
순이익/손실:
$-12.88M
주가수익비율:
-1.5249
EPS:
-2.3215
순현금흐름:
$-10.85M
1주 성능:
+5.36%
1개월 성능:
+17.80%
6개월 성능:
-34.72%
1년 성능:
-83.63%
1일 변동 폭
$3.41
$3.7325
1주일 범위
$3.07
$3.80
52주 변동 폭
$2.7375
$20.97
프로세사 파마슈티컬스 Stock (PCSA) Company Profile
명칭
Processa Pharmaceuticals Inc
전화
443-776-3133
주소
601 21ST STREET, SUITE 300, VERO BEACH
PCSA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PCSA
Processa Pharmaceuticals Inc
|
3.54 | 8.41M | 0 | -12.88M | -10.85M | -2.3215 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
프로세사 파마슈티컬스 Stock (PCSA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-04-25 | 개시 | H.C. Wainwright | Buy |
프로세사 파마슈티컬스 주식(PCSA)의 최신 뉴스
Alliance Entertainment and Processa Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Holland Sentinel
Stock Recap: Is Processa Pharmaceuticals Inc showing insider buying2025 Market WrapUp & Real-Time Market Sentiment Reports - baoquankhu1.vn
Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference to Discuss NGC-Cap Phase 2 Study Results - Quiver Quantitative
Breast cancer trial data in focus as Processa joins major health event - Stock Titan
Is Processa Pharmaceuticals Inc. stock supported by strong cash flowsMarket Risk Report & Fast Gain Swing Trade Alerts - Улправда
How Processa Pharmaceuticals Inc. stock reacts to oil pricesWeekly Gains Summary & Technical Buy Zone Confirmation - Улправда
Star Tribune - FinancialContent
Will Processa Pharmaceuticals Inc. stock outperform value stocksLayoff News & Capital Efficiency Focused Strategies - Улправда
Processa Pharmaceuticals and 60 Degrees Pharmaceuticals Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - The Progress Index
Processa Pharmaceuticals Regains Nasdaq Minimum Bid Compliance - TipRanks
Processa Pharmaceuticals completes enrollment for NGC-Cap breast cancer study - Investing.com Nigeria
Processa Pharmaceuticals completes enrollment of 20th patient in Phase 2 study - TipRanks
Processa Pharmaceuticals (PCSA) Advances in Phase 2 Cancer Study - GuruFocus
Processa Pharmaceuticals completes enrollment for NGC-Cap breast cancer study By Investing.com - Investing.com South Africa
Processa Pharmaceuticals Completes Patient Enrollment for Phase 2 Clinical Study of NGC-Cap in Advanced Breast Cancer, Interim Data Expected Q1 2026 - Quiver Quantitative
Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study - The Manila Times
Processa Pharmaceuticals Inc. (PCSA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
User | chroniclejournal.comProcessa Pharmaceuticals, Inc.Common Stock (Nasdaq:PCSA) Stock Quote - FinancialContent
Why did Processa Pharmaceuticals stock surge 160% today? - MSN
Oracle, Hut 8, Processa Pharmaceuticals, Recursion Pharmaceuticals, Udemy: Stocks making the biggest moves today - MSN
프로세사 파마슈티컬스 (PCSA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
프로세사 파마슈티컬스 주식 (PCSA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Ng George K | Chief Executive Officer |
Jan 27 '25 |
Buy |
0.80 |
87,200 |
69,542 |
87,200 |
| Young David | Pres. Research & Development |
Jan 27 '25 |
Buy |
0.80 |
124,500 |
99,289 |
205,405 |
| Lin Patrick | Chief Business - Strategy Off |
Jan 27 '25 |
Buy |
0.80 |
43,500 |
34,691 |
43,500 |
4.73%
0.92%
자본화:
|
볼륨(24시간):